Trial Details
RECRUITINGBasic Information
| Clinical ID | c391 |
|---|---|
| Identifier | NCT06681012 |
| Trial Title | Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome (IBS)|Irritable Bowel Syndrome of Diarrhea Type (IBS-D) |
| Interventions | DEVICE: Gelsectan®|DRUG: Placebo |
Participant Information
| Sponsor | Devintec Sagl |
|---|---|
| City | Leuven |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2024-10-22 |
|---|---|
| Primary Completion Date | 2027-07 |
| Completion Date | 2027-07 |